Thomas Flaten
Stock Analyst at Lake Street
(4.12)
# 1,634
Out of 5,090 analysts
340
Total ratings
45.1%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXH MDxHealth | Downgraded: Hold | $5 → $0.5 | $0.1633 | +206.18% | 15 | Oct 16, 2026 | |
| PTHS Pelthos Therapeutics | Reiterated: Buy | $50 → $40 | $9.40 | +325.53% | 8 | Oct 12, 2026 | |
| ATHE Alterity Therapeutics | Reiterated: Buy | $10 | $2.16 | +362.96% | 3 | Oct 5, 2026 | |
| HROW Harrow | Reiterated: Buy | $60 | $28.24 | +112.46% | 21 | Oct 5, 2026 | |
| AEON AEON Biopharma | Reiterated: Buy | $1 → $2 | $0.274 | +629.93% | 3 | Oct 1, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $9 | $0.8022 | +1,021.91% | 5 | Oct 1, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $57 | $37.16 | +53.39% | 26 | Oct 1, 2026 | |
| VRCA Verrica Pharmaceuticals | Reiterated: Buy | $9 | $3.35 | +168.66% | 2 | Oct 1, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $40 | $23.26 | +72.01% | 15 | Sep 24, 2026 | |
| AYTU Aytu BioPharma | Reiterated: Buy | $7 | $1.93 | +262.69% | 7 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $4.54 | +340.53% | 1 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.89 | +54.24% | 38 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.93 | +207.17% | 26 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $15.82 | +2.72% | 32 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $2.96 | +305.41% | 26 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.7359 | +851.22% | 9 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $9.25 | +51.35% | 23 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.17 | +151.45% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $14.47 | +65.86% | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $6.83 | +61.05% | 30 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 15 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 | $0.0001 | n/a | 8 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $15 | $0.421 | n/a | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $1.95 | n/a | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $50 | $50.01 | n/a | 4 | Mar 1, 2022 |
MDxHealth
Oct 16, 2026
Downgraded: Hold
Price Target: $5 → $0.5
Current: $0.1633
Upside: +206.18%
Pelthos Therapeutics
Oct 12, 2026
Reiterated: Buy
Price Target: $50 → $40
Current: $9.40
Upside: +325.53%
Alterity Therapeutics
Oct 5, 2026
Reiterated: Buy
Price Target: $10
Current: $2.16
Upside: +362.96%
Harrow
Oct 5, 2026
Reiterated: Buy
Price Target: $60
Current: $28.24
Upside: +112.46%
AEON Biopharma
Oct 1, 2026
Reiterated: Buy
Price Target: $1 → $2
Current: $0.274
Upside: +629.93%
Connect Biopharma Holdings
Oct 1, 2026
Reiterated: Buy
Price Target: $9
Current: $0.8022
Upside: +1,021.91%
Castle Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: $57
Current: $37.16
Upside: +53.39%
Verrica Pharmaceuticals
Oct 1, 2026
Reiterated: Buy
Price Target: $9
Current: $3.35
Upside: +168.66%
Biodesix
Sep 24, 2026
Reiterated: Buy
Price Target: $40
Current: $23.26
Upside: +72.01%
Aytu BioPharma
Sep 23, 2026
Reiterated: Buy
Price Target: $7
Current: $1.93
Upside: +262.69%
Sep 23, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $4.54
Upside: +340.53%
Sep 17, 2026
Reiterated: Buy
Price Target: $6
Current: $3.89
Upside: +54.24%
Aug 21, 2026
Reiterated: Buy
Price Target: $9
Current: $2.93
Upside: +207.17%
Aug 21, 2026
Reiterated: Hold
Price Target: $16
Current: $15.82
Upside: +2.72%
Aug 18, 2026
Reiterated: Buy
Price Target: $12
Current: $2.96
Upside: +305.41%
Aug 10, 2026
Reiterated: Buy
Price Target: $7
Current: $0.7359
Upside: +851.22%
Jun 23, 2026
Reiterated: Buy
Price Target: $14
Current: $9.25
Upside: +51.35%
May 14, 2026
Reiterated: Buy
Price Target: $13
Current: $5.17
Upside: +151.45%
May 8, 2026
Reiterated: Buy
Price Target: $24
Current: $14.47
Upside: +65.86%
Apr 15, 2026
Reiterated: Buy
Price Target: $11
Current: $6.83
Upside: +61.05%
May 15, 2025
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a
Nov 29, 2023
Reiterated: Buy
Price Target: $1.5
Current: $0.0001
Upside: n/a
Apr 12, 2023
Reiterated: Buy
Price Target: $96 → $15
Current: $0.421
Upside: n/a
Sep 16, 2022
Reiterated: Buy
Price Target: $3.5
Current: $1.95
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $60 → $50
Current: $50.01
Upside: n/a